Current NDC auxiliary source row compounder:2621

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 82396-123
Product Ndc: 82396-123
Product Ndc Digits: 82396123
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Ephedrine Sulfate
Proprietary Name Suffix: [empty]
Nonproprietary Name: Ephedrine Sulfate
Dosage Form Name: INJECTION, SOLUTION
Route Name: INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: ANNOVEX PHARMA, INC.
Establishment Name: ANNOVEX PHARMA, INC.
Establishment Fei: [empty]
Substance Name: EPHEDRINE SULFATE
Active Ingredients Info: 5 mg/1 mL
History Active Ingredients Raw: EPHEDRINE SULFATE
History Active Ingredients Info Raw: 5 mg/1 mL
History Dosage Raw: INJECTION, SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 82396-123-10
Package Ndc: 82396-123-10
Package Ndc Digits: 8239612310
Package Ndc11: 82396012310
Package Description: 10 mL in 1 SYRINGE, PLASTIC (82396-123-10)
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:2621
Source Row Number: 2621
Source Row Hash: 2d9a003140e3fce29c69670f1f2f74ddb4ee97f67955208c3f7be4b452fa8c3f
Import Run Id: 20261024T140201Z
Loaded At: 2026-10-24 14:07:01

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "82396-123",
    "DEASCHEDULE": "",
    "LABELERNAME": "ANNOVEX PHARMA, INC.",
    "SUBSTANCENAME": "EPHEDRINE SULFATE",
    "DOSAGEFORMNAME": "INJECTION, SOLUTION",
    "NDCPACKAGECODE": "82396-123-10",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Ephedrine Sulfate",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "Ephedrine Sulfate",
    "PACKAGEDESCRIPTION": "10 mL in 1 SYRINGE, PLASTIC (82396-123-10) ",
    "ACTIVEINGREDIENTSINFO": "5 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:2621
Source Row Number: 2621
Status Scope: package
Lookup Ndc: 82396-123-10
Lookup Ndc Digits: 8239612310
Product Ndc: 82396-123
Product Ndc Digits: 82396123
Package Ndc: 82396-123-10
Package Ndc Digits: 8239612310
Package Ndc11: 82396012310
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 2d9a003140e3fce29c69670f1f2f74ddb4ee97f67955208c3f7be4b452fa8c3f
Import Run Id: 20261024T140201Z
Loaded At: 2026-10-24 14:07:01